Guidance is flat though. Hopefully it’s conservative and can surprise on the upside
Printable View
Guidance is flat though. Hopefully it’s conservative and can surprise on the upside
Close at $2.86 today means it is a Buy again now? A bit of a "pop and flop" stock as some have said, and now at the "flop" mark in the cycle.
The token dividend is due later this week. I wonder if the ASM on 2 August will add any momentum?
Not much price action despite recent announcements, including the last annual result.
Calendar 2025 looks promising off a base of reduced debt, and major product launches in the US and China. Probably a good choice as a pick for the 2025 sharetrader competition given the potential. Is anyone looking that far ahead?
Chairman's address:
https://www.nzx.com/announcements/435498
I resonate with the comment made by the Chair: "but to value the company’s shares at a price that is largely unchanged from when we joined the NZX and ASX is inconsistent with the progress we have made."
The current share price is essentially a function of the minimal dividend paid. In this country many investors look no further.
I see AFT as a pick for the 2025 sharetrader competition if it doesn't move much before then.
And I am a very small holder currently but absent capital just now to allocate to acquiring more.
another good news day, another SP upset day. The board really needs some communications among financial institutions.
AFT share price going so well lately it’ll be over $3.50 soon and heading to $4.00 plus
Hope you picked up more Ronaldson
Sadly no. The last of my "readies" went on HGH at $1.06 last Friday. Waiting for the late September dividend stream from CEN, SPK, KFL, MCY, HGH and ARG to come to hand, although all on DRIP currently except ARG which allows me to survive another 3 months in these high cost times. Looking back after retiring about 12 years ago now I was naive about the cost of living changes to come!